(Q47894243)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818096%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Mirtazapine does not improve sleep disorders in Alzheimer's disease: results from a double-blind, placebo-controlled pilot study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818096%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

0 references

1 reference

Otávio Toledo Nóbrega

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818096%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Francisca M Scoralick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818096%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Luciana L Louzada

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818096%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Juliana L Quintas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818096%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Janeth O S Naves

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818096%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Einstein F Camargos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818096%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

27 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818096%20AND%20SRC:MED&resulttype=core&format=json

Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818096%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818096%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818096%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

89-96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818096%20AND%20SRC:MED&resulttype=core&format=json

Predictors of institutionalization for people with dementia living at home with a carer

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

The management of sleep and circadian disturbance in patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

Drugs used to treat insomnia in 2002: regulatory-based rather than evidence-based medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

Mianserin for the treatment of sleep disorders in patients with dementia: a retrospective open-label study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

Serotonin 5-HT(2A) receptor antagonists in the treatment of insomnia: present status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

Trazodone for the treatment of sleep disorders in dementia: an open-label, observational and review study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

Mirtazapine for treatment of depression and comorbidities in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

The efficacy of mirtazapine in agitated patients with Alzheimer's disease: A 12-week open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

Development of diagnostic criteria for defining sleep disturbance in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

A new clinical scale for the staging of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

Cornell Scale for Depression in Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

Mirtazapine as positive control drug in studies examining the effects of antidepressants on driving ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

A Review of the Pharmacological and Clinical Profile of Mirtazapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

Regression towards the mean

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

Mirtazapine orally disintegrating tablets in depressed nursing home residents 85 years of age and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

Can mirtazapine counteract the weight loss associated with Alzheimer disease? A retrospective open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

Use of historical control data for assessing treatment effects in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

Wrist actigraphy for measuring sleep in intervention studies with Alzheimer's disease patients: application, usefulness, and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12191

21 January 2018

Identifiers

DOI

10.1111/PSYG.12191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818096%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference